Lv54
1030 积分 2026-05-02 加入
The tumour microenvironment and immune milieu of cholangiocarcinoma
5天前
已完结
Prognostic impact of tumor microenvironment characteristics in intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
9天前
已完结
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
11天前
已完结
Benefit from pemigatinib in cholangiocarcinoma
11天前
已完结
New Horizons for Precision Medicine in Biliary Tract Cancers
11天前
已完结
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
11天前
已完结
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
11天前
已完结
New Horizons for Precision Medicine in Biliary Tract Cancers
11天前
已关闭
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
12天前
已完结
Molecular pathogenesis of cholangiocarcinoma
12天前
已完结
皖公网安备34019202002308
